Medifast, Inc. announced that Timothy G. Robinson, chief financial officer, will be stepping down from his position at the company on March 31, 2020.
Medifast Chief Executive Officer Dan Chard and the Board of Directors have retained a leading international executive search firm to help the company identify and appoint a long-term successor to Robinson.
Joseph Kelleman has been appointed interim chief financial officer to lead the finance function until a permanent appointment is made. He has had a distinguished career with Medifast since joining in 2012, serving in a series of senior financial roles in that time including corporate controller and vice president of Finance. He also served as interim chief financial officer of the company prior to Robinson’s appointment in 2013.
“Tim has been an important member of the team in his seven years at Medifast, and we wish him all the best in his future endeavors,” said Dan Chard. “We are at an exciting point in our company’s journey, having driven rapid growth and executing the development of an infrastructure to support significant incremental growth over the coming years. We are well positioned to build on our success in the United States and in Asia, as we move forward in our mission to offer the world lifelong transformation one healthy habit at a time.